Establishment Labs Holdings Inc. - Common Shares (ESTA)

QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings.

Stride delivers online and blended education solutions for K-12, career, and adult learners through proprietary technology platforms.

Establishment Labs (ESTA) Earnings Transcript

One fund just walked away from a rising offshore driller—here’s what long-term investors should make of the move.

A fast-growing niche segment may be the real reason this small-cap consumer products stock is drawing new institutional attention.

One small fund’s high-conviction move offers a window into how specialists are navigating 2025’s biotech rally.

Establishment Labs (ESTA) Earnings Transcript

Establishment Labs (ESTA) Q3 2025 earnings beat expectations with strong revenue growth and a narrower loss, raising its full-year outlook.

Establishment Labs (ESTA) reports Q2 2025 earnings with $51.3M revenue (+16.3% YoY), beating estimates. Loss narrows to $16.6M. U.S. growth drives outlook, but cash burn remains a concern. Stock shows cautious optimism.

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.